Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.28 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.28 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
7.28 | 10697514 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
11.34 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.34 | 6695378 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
11.34 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.58 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.64 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.39 | 11369114 14761424 17661222 |
MESH:D015783 |
Aniridia |
marker/mechanism |
|
| 18322702 |
MESH:C536370 |
Aniridia cerebellar ataxia mental deficiency |
marker/mechanism |
|
| |
MESH:C536372 |
Aniridia, type 2 |
marker/mechanism |
|
| |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.09 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.35 | 16456186 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18322702 |
OMIM:180500 |
AXENFELD-RIEGER SYNDROME, TYPE 1 |
marker/mechanism |
|
| 14630904 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.44 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.03 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.03 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.29 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.76 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.89 | 11985600 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.91 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
15.00 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
15.00 | 16651633 18412241 16357521 16436596 15144691 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
15.00 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
4.76 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.76 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.76 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
4.76 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.76 | 11325840 15567936 17983394 16096432 15993339 16264153 15994142 19526202 15692762 18628466 15634643 17426702 16935488 15939500 17369602 18382427 16595493 15136595 16322301 18695136 16826403 16115903 15668708 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
4.76 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.76 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.76 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.64 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.87 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.22 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.68 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.68 | 16234567 16023760 18059187 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
6.68 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.68 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.04 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.59 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.59 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.45 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
14.45 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
14.45 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
14.45 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.45 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.55 | 16952015 16269455 17131338 17308081 16612575 16731534 16364871 16651473 16278810 15476868 16455267 17329180 17928571 17519947 17924179 17351982 15792986 17974986 17007740 15505089 16242529 17382496 15811867 18627295 16109756 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.95 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.11 | 17460283 |
OMIM:604219 |
CATARACT, AUTOSOMAL DOMINANT |
marker/mechanism |
|
| |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.38 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.38 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
11.38 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.05 | 17160924 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
13.15 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
13.15 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.95 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.95 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.22 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.80 | 15668235 16354765 12621046 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.80 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.75 | 17035595 |
MESH:D003103 |
Coloboma |
marker/mechanism |
|
| |
MESH:C535970 |
Coloboma of optic nerve |
marker/mechanism |
|
| |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.62 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.62 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
3.62 | 17273769 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 7559133 9079035 9363853 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
3.85 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.85 | 9125849 10589399 8800419 16925845 9664655 17551590 14991402 9142499 9211117 9224671 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.81 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 18759878 2524372 12868966 14531868 11298694 11906362 8156756 8970840 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
9.10 | 11289319 9022650 18648102 18289764 9328219 18692083 8291058 16192314 1440618 9653073 6679447 7440962 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
9.10 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
9.10 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.10 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.18 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.18 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.05 | 18357618 |
MESH:C536185 |
Ectopia pupillae |
marker/mechanism |
|
| |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.16 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.16 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.18 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.65 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.65 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.22 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.38 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.38 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.90 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.90 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.88 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.64 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.98 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.98 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.98 | 17994277 |
OMIM:136520 |
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME |
marker/mechanism |
|
| |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
17.18 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
17.18 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
17.18 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
17.18 | 17312396 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.50 | 18412241 16651633 16357521 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
13.10 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
13.10 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
13.10 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.22 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.17 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.17 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.17 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.50 | 17875725 16144979 16879835 16244371 16495754 16707910 18006777 16330681 16244372 12587719 18674790 14766674 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.36 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.93 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.69 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.93 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.43 | 18501091 17606976 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 18606429 15340226 8697196 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.23 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.61 | 16778211 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
8.67 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.67 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.67 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.22 | 17581917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.31 | 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.81 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.03 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.03 | 15992940 17551590 |
MESH:C537022 |
Keratitis, hereditary |
marker/mechanism |
|
| |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.16 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.16 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.18 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.63 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.63 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
12.63 | 17379185 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.11 | 16316344 |
MESH:D007938 |
Leukemia |
|
Benzene |
10.66 | 18335105 14694614 17119257 15935818 |
MESH:D007938 |
Leukemia |
|
decitabine |
10.66 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
10.66 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.22 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
16.25 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
16.25 | 18454857 17236224 19117987 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
16.25 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
6.26 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.26 | 19387464 18460780 17679729 19010910 18704418 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.26 | 16294345 19850784 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.52 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.17 | 16766008 17361223 16935935 16891316 17368321 16788101 9834237 17649720 12679006 17107899 17217047 17712046 16140955 17294898 17506722 19642359 15748426 17339181 19035177 19075265 19029980 19225113 16331271 16823087 17301526 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
6.11 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.33 | 9224671 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.52 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.52 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.52 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.36 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.36 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.30 | 598648 1399818 6587162 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
14.30 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.30 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.30 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.87 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
6.65 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.65 | 20064080 6695378 20464547 18569708 17053015 18816296 18520028 20135361 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.65 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
6.65 | 17703301 16271038 6695378 16019985 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.65 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Benzene |
18.12 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
decitabine |
18.12 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
18.12 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
18.12 | 15790496 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.81 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
11.84 | 15621674 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
11.84 | 15375218 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.49 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
14.55 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
14.55 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
14.55 | 18041768 10767621 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
14.55 | 10697514 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.79 | 17453147 |
MESH:D008545 |
Melanoma |
marker/mechanism |
|
| 16778180 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.41 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.41 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
7.41 | 16270382 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.41 | 16752155 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.05 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.47 | 16940565 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 18322702 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.07 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.53 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.85 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.85 | 16274795 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.84 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
7.65 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.65 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.53 | 19157545 16882708 19010910 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.53 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.96 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.88 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.88 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
12.04 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
12.04 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
12.04 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
12.04 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.44 | 16707424 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.81 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.38 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.38 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
16.60 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.60 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
16.60 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
12.31 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
12.31 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
12.31 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.47 | 16003739 17160924 16651423 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.27 | 15555623 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.73 | 16303764 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
9.25 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
9.25 | 16737584 15576619 15727169 15612468 15913788 17479406 15935809 17119257 17178637 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.05 | 17160924 |
MESH:D009901 |
Optic Nerve Diseases |
marker/mechanism |
|
| 12721955 |
OMIM:165550 |
OPTIC NERVE HYPOPLASIA, BILATERAL |
marker/mechanism |
|
| |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.80 | 17882678 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.13 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.04 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
11.45 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.45 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
11.45 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.45 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.92 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.83 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
8.83 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.83 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:C537884 |
Peters anomaly |
marker/mechanism |
|
| |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.22 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.22 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.68 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.68 | 11118676 11896295 11222880 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.77 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.24 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.12 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.12 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.12 | 15749863 16868541 16888761 15897917 16729912 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.12 | 17024972 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.64 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.84 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.84 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.26 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
9.18 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
9.18 | 16303925 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.06 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.06 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.01 | 15675481 15625365 17710206 18313854 17203757 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.28 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.84 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
22.66 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
22.66 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
22.66 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
22.66 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
22.66 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
22.66 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.61 | 15625365 17203757 16767912 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 16367923 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
4.77 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.77 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.77 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.77 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.03 | 16045194 16684133 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
12.37 | 10850423 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
12.37 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.31 | 3712494 6582329 1399818 7505956 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
17.31 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
17.31 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
17.31 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.81 | 16051514 |
MESH:D014071 |
Tooth Abnormalities |
marker/mechanism |
|
| 7559133 9363853 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.24 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.94 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
15.94 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
15.94 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
15.94 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
15.94 | 16720286 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
9.79 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.79 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.07 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
4.37 | 12562636 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
13.04 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
13.04 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.26 | 17678736 17638931 17334414 16364871 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.09 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.99 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |